Little Green Pharma (ASX:LGP) Long-Term Debt: A$2.23 Mil (As of Mar. 2026)


What is Little Green Pharma Long-Term Debt?

Little Green Pharma ASX:LGP +1.49% Long-Term Debt is A$2.23 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Little Green Pharma's Long-Term Debt for the quarter that ended in Mar. 2026 was A$2.23 Mil.

Little Green Pharma's quarterly Long-Term Debt increased from Mar. 2025 (A$0.78 Mil) to Sep. 2025 (A$3.75 Mil) but then declined from Sep. 2025 (A$3.75 Mil) to Mar. 2026 (A$2.23 Mil).

Little Green Pharma's annual Long-Term Debt declined from Mar. 2024 (A$1.14 Mil) to Mar. 2025 (A$0.78 Mil) but then increased from Mar. 2025 (A$0.78 Mil) to Mar. 2026 (A$2.23 Mil).

Little Green Pharma  (ASX:LGP) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Little Green Pharma Long-Term Debt Related Terms

Little Green Pharma Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Little Green Pharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Little Green Pharma Long-Term Debt Chart

Little Green Pharma Annual Data
Trend Jun19 Jun20 Jun21 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial 0.00 5.28 1.14 0.78 2.23

Little Green Pharma Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.14 2.40 0.78 3.75 2.23
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of A$2.23 Mil mean?
Little Green Pharma (ASX:LGP) has a Long-Term Debt of A$2.23 Mil as of Mar. 2026.
Is Little Green Pharma's Long-Term Debt too high?
Little Green Pharma's current Long-Term Debt is A$2.23 Mil.
How does Little Green Pharma's Long-Term Debt compare to ZTS and UTHR?
Little Green Pharma's Long-Term Debt of A$2.23 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Little Green Pharma's current Long-Term Debt is A$2.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.17, compared to a current price of A$0.07 — trading 60% below its estimated fair value. The current Long-Term Debt is A$2.23 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current Long-Term Debt is A$2.23 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Little Green Pharma Business Description

Address 13A Bedbrook Place, Shenton Park, West Perth, Perth, WA, AUS, 6008
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).